Cart
sales@molnova.com
Rosavin
CAS No. 84954-92-7
Rosavin( Rosavin | )
Catalog No. M19178 CAS No. 84954-92-7
Rosavin has antidepressant and anxiolytic actions, helps balance all the neurotransmitters.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 5MG | 40 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 176 | In Stock |
|
| 100MG | 262 | In Stock |
|
| 200MG | 389 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRosavin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRosavin has antidepressant and anxiolytic actions, helps balance all the neurotransmitters.
-
DescriptionRosavin is a bioactive antidepressant component isolated from Rhodiola rosea L.
-
In Vitro——
-
In Vivo——
-
SynonymsRosavin |
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCYP3A4
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number84954-92-7
-
Formula Weight428.43
-
Molecular FormulaC20H28O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (233.41 mM)
-
SMILESO1[C@H]([C@@H]([C@H]([C@@H]([C@H]1CO[C@@H]1OC[C@@H]([C@@H]([C@H]1O)O)O)O)O)O)OC/C=C/c1ccccc1
-
Chemical Name(2R,3R,4S,5S,6R)-2-(cinnamyloxy)-6-((((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Grech-Baran M1,et al. Biotechnol Lett. 2014 Mar;36(3):649-56.
molnova catalog
related products
-
NVP-2
NVP-2 is a?potent, selective, ATP-competitive CDK9 inhibitor with IC50 of <0.514 nM (CDK9/CyclinT).
-
Dalpiciclib
Dalpiciclib is a highly selective, orally bioavailable, and comparable potency inhibitor of CDK4 and CKD6 with IC50s of 12.4?nM and 9.9?nM, respectively.
-
Amsilarotene
Amsilarotene inhibits the phosphorylation of retinoblastoma gene product (RB) and increases the presence of 2 cyclin-dependent kinases (CDK) inhibitors resulting in cell cycle arrest.
